Pause of AZD1222 vaccine by some EU countries (Germany, Denmark, etc.) when UK has not raised any concerns, is relevant for India because > 85% of vaccine currently being admin in India is COVISHIELD (SII's AZD1222).

Thread on safety data from MHRA,UK

\1
Up to 28 Feb 2021:

1st doses of COVID19 vaccines administered by UK

- 10.7 million of BNT162b2

- 9.7 million of AZD1222

& ~ 0.8 million 2nd doses mostly of BNT162b2.

AEFIs reported via Yellow card:

- 94809 of BNT162b2

- 201622 of AZD1222

- 843 unspecified

\2 Image
Up to Feb 28, 2021 in UK:

~10.1 million received Pfizer/BioNTech's mRNA vaccine, whereas 9.7 million received AZ/Oxford vaccine

Deaths reported via Yellow card:

- 251* of BNT162b2

- 275* of AZD1222

- 6 unspecified

% of deaths in vaccine recipients: AZD1222 > BNT162b2

\3 ImageImageImage
Blood disorders: 1098 @ AZD1222, 2294 @ BNT162b2

where, Thrombocytopenias: 35 @ AZD1222, 22 in BNT162b2

- Immune Thrombocytopenia: 22 (1 death) @ AZD1222, 9 @ BNT162b2

- Thrombocytopenia: 12 @ AZD1222, 13 (1 death) @ BNT162b2

- Thrombocytopenic purpura: 1 in AZD1222

\4 ImageImage
Cardiac disorders: 1922 (39 death) @ AZD1222, 1153 (26 death) @ BNT162b2

Deaths from

- Myocardial infarction: 12 @ AZD1222, 6 @ BNT162b2

- Myocardial ischaemia: 3 in AZD1222

- Heart failures NEC: 5 @ AZD1222, 2 @ BNT162b2

- Cardiac arrest: 13 @ AZD1222, 15 @ BNT162b2

\5 ImageImageImageImage
Eye disorders: 2150 @ AZD1222, 1398 @ BNT162b2

Gastrointestinal disorders: 22336 (5 deaths) @ AZD122, 10534 (12 deaths) @ BNT162b2

General disorders: 71732 (153 death) @ AZD122, 128915 (114 death) @ BNT162b2

Infections: 3839 (38 death) @ AZD122, 2059 (38 death) @ BNT162b2

\6 ImageImage
Immune system disorders: 542 @ AZD122, 528 @ BNT162b2

Metabolic disorders: 2644 (1 death) @ AZD122, 587 (1 death) @ BNT162b2

Muscle & tissue disorders: 24631 @ AZD122, 12823 @ BNT162b2

Nervous system disorders: 43951 (19 deaths) @ AZD122, 18059 (17 deaths) @ BNT162b2

\7 ImageImage
Psychiatric disorders: 3554 @ AZD122, 1409 @ BNT162b2

Reproductive & breast disorders: 297 @ AZD122, 389 (1 death) @ BNT162b2

Respiratory disorders: 5323 (11 death) @ AZD122, 3986 (14 death) @ BNT162b2

\8
------------------

Yellow card reports: gov.uk/government/pub… ImageImage
👉A comprehensive summary of key points from European Medical Agency's assessment of Thromobocytopenia.

Key confirmation from EMA's safety committee:

1. Benefits of AZD1222 (COVISHIELD) still outweigh the risks despite possible link to rare blood clots with low blood platelets. ImageImage
2. No evidence of a problem related to specific batches of the vaccine or to particular mfg sites.

3. the vaccine may be associated w/ very rare cases of blood clots associated w/ thrombocytopenia, i.e. low levels of blood platelets (elements in the blood that help it toclot) w/ Image
or w/o bleeding, including rare cases of clots in vessels draining blood from the brain (CVST).

~20 million people in UK & EEA had got vaccine as of 16 March & EMA had reviewed only 7 cases of blood clots in multiple blood vessels (disseminated intravascular coagulation, DIC) & Image
18 cases of CVST. A causal link w/ thevaccine is not proven, but is possible and deserves further analysis.

9 of DIC & CVST cases from member states resulted in deaths. Most of these occurred in people < 55 years & majority were women👩.

Difficult to look at background rate. Image
However, based on pre-COVID figures it was calculated
that < 1 reported case of DIC might have been expected by 16 March among people < 50 w/in 14 days of receiving vaccine, whereas 5 cases had been reported. Similarly, on avg 1.35 cases of CVST might have been expected among Image
this age group whereas by the same cut-off date there had been 12.

Press brief on EMA assessment here: ema.europa.eu/en/news/covid-…



Information for vaccine recipients (left pic) and health professionals (right pic): ImageImage
🚨 (Amended) Product Information of AstraZeneca/Oxford COVID19 vaccine (COVISHIELD if mfg by SII, India) as approved by CHMP, @EMA_News on 19 March 2021, pending endorsement by @EU_Commission: ema.europa.eu/en/documents/p…

Product Info of COVISHIELD in India also needs to be updated. ImageImage
Seek immediate medical attention if AEFI like

- shortness of breath, chest pain, leg swelling, or
persistent abdominal pain

- severe or persistent headaches or blurred vision, or experience skin bruising or pinpoint round spots beyond site of jab which appears after a few days ImageImageImage
Based on clinical/laboratory features of 9 patients in Germany & Austria, a study finds: AZD1222 is associated w/ development of prothrombotic disorder that clinically resembles heparin-induced thrombocytopenia but which shows different serological profile researchsquare.com/article/rs-362… Image
At least 4 cases in India of thrombocytopenia post COVISHIELD, includes-

33yr/F (vaccine: 22 Jan, death: 3 Feb) w/ death cause earlier reported as "cerebral thrombosis" after post-mortem

80yr/M: AEFI- low platelets initially, later intracranial bleeding
ImageImageImage
Bijwerkingencentrum Lareb, Netherlands has received 5 reports of extensive thrombosis w/ a low platelet count following vaccination with Vaxzevria (COVISHIELD). It occurred 7 to 10 days after vaccination. These are women between 25 & 65 years old. lareb.nl/news/meldingen… Image
Vaxzevria (COVISHIELD): As of 4 April 2021, 169 cases of CVST & 53 cases of splanchnic vein thrombosis reported to EudraVigilance.

🚨EMA has concluded that unusual blood clots w/ low blood platelets should be listed as very rare side effects of Vaxzevria.
ema.europa.eu/en/news/astraz… ImageImage
A short commentary on @MHRAgovuk assessment of reported very rare AEFI: specific blood clots (thrombosis) with low platelets count (thrombocytopenia) associated w/ Vaxzevria (COVISHIELD).

1. Benefits of vaccine outweighs risk for vast majority of people. By 31 March, 20 million
doses have been give. MHRA had 79 case reports upto & including 31st March, 19 people died. All cases post 1st dose. Cases occurred in 51 women and 28 men, all in age group 18 to 79 years.

2. Risk of this rare blood clot about 4 people in a million. Among deceased, 3 out of 19
under 30 years. 4 out of 19 were of cerebral venous sinus thrombosis w/ low platelets, and 5 were other kinds of thrombosis in major veins.

3. Balance of benefits to risk is very favorable in older people & more finely balanced in younger people. Advise on how to minimize risk.
4. Anyone w/ symptoms 4 or more days post vaccination should seek prompt medical advice, new onset of a severe or persistent headache or blurred vision, shortness of breathe, chest pain, leg swelling, persistent abdominal pain, or indeed unusual skin bruising or pinpoint spots.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with सिद्धार्थ

सिद्धार्थ Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @das_seed

13 Jul 20
Restricted Use of #Itolizumab for CRS in moderate to severe ARDS patients due to #COVID19. No peer-review.

❗️Phase III clinical trial exempted, to go for Phase IV.

Wordings of SEC meeting & Dr Sandeep Athalye, Chief Medical Officer, Biocon Biologics, have similar tone. 👇
To understand how HUGE scientific rationale can be, check her discussion w/ @SadhguruJV, a repeat offender. She speaks on DATA as well.

Both spewed lot of misinformation & judgement that could endanger public health & lives.

How are major arguments used by @kiranshaw here not different than arguments made by @yogrishiramdev on #CORONIL? Both playing on emotions like "made in India", "used since ages", "rigorous clinical trials not so relevant in pandemic". @CDSCO_INDIA_INF

Read 31 tweets
10 Jul 20
🚩What is community transmission? Is India under community transmission?
⚠️What are implications of community transmission? Why is @MoHFW_INDIA denying it?
🧐What are possible consequences if there's declaration of community transmission? How will it help public? (thread)\1
@WHO's definition of community transmission allows govts to announce/deny community transmission based on their agenda. Maybe vague but @MoHFW_INDIA is NOT in position to defend its denial. "COMMUNITY TRANSMISSION" is officially used in @MoHFW_INDIA's critical policy/rules. \2
March 23 by 1800 IST, 2020, we officially had 433 COVID-19 cases, 7 deaths, 402 active. @PMOIndia declares nationwide strict lockdown for ~2 months. Only few places officially had local transmission on. Today, 25 states/UTs have 500+ active cases each. \3
Read 15 tweets
6 Jul 20
🚩Unprecedented time demands pertinent questions.

IMO, we are often not asking questions appropriate to priority.

e.g.,

1. Ask about quality, quantity, delivery status of medical devices (PPE, N95 masks, ventilators, sanitizers, etc.). NOT price even if its via #PMCARES. \1
Lives are getting lost due to delay, low quality, shortage while disease keeps spreading. You need to save healthcare workers else who will take care of patients even if we keep adding beds.

Money NOT an issue, have $2250 million loan from World Bank+ AIIB alone for COVID18.\2
Need obsession w/ saving lives & economy of country. We can ask about #PMCARES even later, but can lives lost due to shortage/quality/delay be brought back? No. Your question should determine your priority goal.

❗️allocation ≠ transaction.

Need patience for balance-check.\3
Read 5 tweets
29 Jun 20
📋CLINICAL MANAGEMENT PROTOCOL: COVID-19 by GoI, @MoHFW_INDIA provides guidance to #COVID19 medicare and mgmt units all over India.

❗️Essential to be FACT-based, well-INFORMED, UPDATED.

⚠️Sadly, its not well-informed or fact-based. Needs URGENT UPDATE/REVISION now. e.g., 👇 Image
❗️Some MISINFORMATION based on outdated @WHO's surveillance guidelines & info (~March '20).

❗️Ignored information post mid-March from EU, USA, India though these form major % of total cases.

❗️ECOLOGICAL FALLACY.

❗️Systematic CALLOUSNESS.
\2 Image
❗️SARS-CoV-2 transmitted from HUMAN-to-HUMAN by infectious droplets, arguably AIRBORNE & ocular mucosa (may also be Faecal-oral).

❗️Asymptomatic: Infected but will never show symptoms.
Pre-symptomatic: Infected & will show symptoms eventually.👇 \3 ImageImageImageImage
Read 14 tweets
4 Jun 20
⚠️Public health @ risk: Misinformation by @PMOIndia @NITIAayog @ICMRDELHI

❗️COMMUNITY TRANSMISSION on.
❗️UTTERLY LIMITED test capacity & medical facility.
❗️NO ESTIMATE FOR % ASYMPTOMATIC, not in India and not for global popn!
❗️still EARLY stage. \1
❗️PRE-SYMPTOMATIC ≠ ASYMPTOMATIC.
❗️Pre-symptomatic can be EXTREMELY contagious as symptomatic ones.
❗️ECOLOGICAL FALLACY is BLUNDER.
❗️Self-ISOLATION/QUARANTINE when suspicious of exposure to infection is MUST. \2
❗️AVERAGE w/o RANGE, CONFIDENCE INTERVAL (where relevant), and SAMPLE SIZE holds too little or NO meaning.
❗️There're LIMITS to STATISTICAL INFERENCE, which SHOULDN'T be ignored.
❗️FORGED data yields USELESS calculation w/ NO valuable inferences even if plots look PRETTY. \3
Read 4 tweets
30 May 20
❗️What're some of India's elite COVID19 calculators (@NITIAayog, @ICMRDELHI, majority of media) getting wrong? Here are some monumental blunders in elementary analysis of numbers related to COVID19 cases in India.
Rule 1: If facts are misrepresented, analysis will be wrong! /1
1. An ecological fallacy: 1st, we keep/kept deducing about the spread of infection in India by inferring global data (avg.).
Same at level of India, focused on average rather than local level data barring few states/districts. Need extensive analysis of data at local level. \2
Examples: We haven't done surveillance test or case study in India to estimate % of asymptomatic case, avg period of incubation, estimate for how much % of popn show symptoms in which week, avg recovery period from day of symptoms onset, etc. We apply arbitrary estimation .... \3
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!